Occlutech International AB (Occlutech) is a medical device company that develops and supplies heart implant products. The company offers occlutech figulla flex II, sizing occlutech ASD, occlutech PDA occluder, figulla flex UNI, occlutech delivery set, and stiff guidewire. It develops stiff guide wire using a stainless steel core with a PTFE coating. Occlutech’s patented technology platform uses nanotechnologies for coating and covering implants. The company’s products are used in the treatment of patent ductus arteriosus, arterial septal defects and the left atrial appendage. It operates through research and development, and production facilities located in Germany, the UK, Italy, France, Benelux, the Nordics, Australia, New Zealand and Canada, among others. Occlutech is headquartered in Helsingborg, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Occlutech International AB
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Category segmentation
1.6. Geography segmentation
1.7. Market rivalry
1.8. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the key strengths of the leading players?
7.3. What are the most recent notable developments of the leading players?
8 Company Profiles
8.1. NatureWorks LLC
8.2. Danimer Scientific Inc
8.3. DuPont de Nemours Inc
8.4. Genomatica Inc
8.5. Eastman Chemical Company
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related GlobalData research
About GlobalData
List of Tables
Table 1: United States bioplastics market value: $ million, 2017–22
Table 2: United States bioplastics market volume: thousand Tonnes, 2017–22
Table 3: United States bioplastics market category segmentation: % share, by value, 2017–2022
Table 4: United States bioplastics market category segmentation: $ million, 2017-2022
Table 5: United States bioplastics market geography segmentation: $ million, 2022
Table 6: United States bioplastics market value forecast: $ million, 2022–27
Table 7: United States bioplastics market volume forecast: thousand Tonnes, 2022–27
Table 8: NatureWorks LLC: key facts
Table 9: NatureWorks LLC: key employees
Table 10: Danimer Scientific Inc: key facts
Table 11: Danimer Scientific Inc: key employees
Table 12: DuPont de Nemours Inc: key facts
Table 13: DuPont de Nemours Inc: annual financial ratios
Table 14: DuPont de Nemours Inc: key employees
Table 15: DuPont de Nemours Inc: key employees Continued
Table 16: Genomatica Inc: key facts
Table 17: Genomatica Inc: key employees
Table 18: Eastman Chemical Company: key facts
Table 19: Eastman Chemical Company: annual financial ratios
Table 20: Eastman Chemical Company: key employees
Table 21: United States size of population (million), 2018–22
Table 22: United States gdp (constant 2005 prices, $ billion), 2018–22
Table 23: United States gdp (current prices, $ billion), 2018–22
Table 24: United States inflation, 2018–22
Table 25: United States consumer price index (absolute), 2018–22
Table 26: United States exchange rate, 2018–22
List of Figures
Figure 1: United States bioplastics market value: $ million, 2017–22
Figure 2: United States bioplastics market volume: thousand Tonnes, 2017–22
Figure 3: United States bioplastics market category segmentation: $ million, 2017-2022
Figure 4: United States bioplastics market geography segmentation: % share, by value, 2022
Figure 5: United States bioplastics market value forecast: $ million, 2022–27
Figure 6: United States bioplastics market volume forecast: thousand Tonnes, 2022–27
Figure 7: Forces driving competition in the bioplastics market in the United States, 2022
Figure 8: Drivers of buyer power in the bioplastics market in the United States, 2022
Figure 9: Drivers of supplier power in the bioplastics market in the United States, 2022
Figure 10: Factors influencing the likelihood of new entrants in the bioplastics market in the United States, 2022
Figure 11: Factors influencing the threat of substitutes in the bioplastics market in the United States, 2022
Figure 12: Drivers of degree of rivalry in the bioplastics market in the United States, 2022